Prognostic value of C-reactive protein measurement in unstable angina;Valor pronóstico de la determinación de la proteína C repactiva en la angina inestable

Revista Espanola de Cardiologia

Volumn 54, Issue 1, 2001, Pages 1-6

  Bazzino, Óscar ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Inflammation; Prognosis; Unstable angina

Indexed keywords

C REACTIVE PROTEIN;

BLOOD; HUMAN; INFLAMMATION; ISCHEMIA; MORTALITY; PROGNOSIS; REVIEW; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; C-REACTIVE PROTEIN; HUMANS; INFLAMMATION; ISCHEMIA; PROGNOSIS;

EID: 0035234201     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(01)76257-4     Document Type: Article

References (62)

1. Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro JH. Insights into the pathogenesis of acute ischemic syndromes. Circulation 1988; 77: 1213-1220.
2. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-250.
3. Constantinides P. Plaque fissures in human coronary thrombosis. J Atheroscler Res 1966; 6: 1-17.
4. Davies MJ, Thomas AC. Plaque fissuring-the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985; 53: 363-373.
5. Davies MJ, Thomas AC. Thrombosis and acute coronary artery lesion in sudden cardiac ischemic death. N Engl J Med 1984; 310: 1137-1140.
6. Chesebro JH, Zoldhelyi P, Fuster V. Plaque disruption and thrombosis in unstable angina pectoris. Am J Cardiol 1991; 68: 9C-15C.
7. Davies MJ, Thomas AC, Knapman PA, Hangartner JR. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 1986; 73: 418-427.
8. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation 1985; 71: 699-708.
9. Kohchi K, Takebayashi S, Hiroki T, Nobuyoshi M. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. Circulation 1985; 71: 709-716.
10. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994; 90: 775-778.
11. Van der Wal, Becker AE, Van der Los Ch, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44.
12. Kaartinen M, Van der Wal A, Van der Loos C, Piek J, Koch K, Becker A et al. Mast cell infiltration in acute coronary syndromes: implications for plaque rupture. J Am Coll Cardiol 1998; 32: 606-612.
13. Shah PK, Falk E, Badimon JJ, Fernández-Ortiz A, Mailhac A, Villareal-Levy G et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995; 92: 1565-1569.
14. Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ et al. The Yin and Yang of oxidation in the development of the fatty streak: the review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 1996; 16: 831-842.
15. Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation 1997; 96: 3264-3265.
16. Stopeck AT, Nicholson AC, Mancini FP, Hajjar DP. Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells. J Biol Chem 1993; 268: 17489-1794.
17. Hajjar DP, Haberland ME. Lipoprotein trafficking in vascular cells: molecular Trojan horses and cellular saboteurs. J Biol Chem 1997; 272: 22975-22978.
18. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1 beta-convening enzyme. Am J Pathol 1995; 147: 251-266.
19. Lacy F, O'Connor DT, Schmid-Schönbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at generic risk of hypertension. J Hypertens 1998; 16: 291-303.
20. Hendrix MG, Salimans MM, Van Boven CP, Bruggeman CA. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990; 136: 23-28.
21. Melnick JL, Adam E, Debakey ME. Cytomegalovirus and atherosclerosis. Eur Heart J 1993; 14 (Supl K): 30-38.
22. Gupta S, Leatham EW, Carrington D, Mendall M, Kaski JC, Camm J et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997; 96: 404-407.
23. Neri Serneri G, Abbate R, Gori A, Attanasio M, Martini F, Giusti B et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992; 86: 790-797.
24. Mazzone A, De Servi S, Ricevuti G, Mazzucchelli L, Fossati G, Pasotti D et al. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993; 88: 358-363.
25. Biasucci LM, D'Onofrio G, Liuzzo G, Zini G, Monaco C, Caligiuri G et al. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol 1996; 27: 611: 1137-1140.
26. Jude B, Agraou B, McFadden EP, Susen S, Bauters C, Lepelley P et al. Evidence for time dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Circulation 1994; 90: 1662-1668.
27. Leatham E, Bath P, Tooze J, Camm A. Increased monocyte tissue factor expression in coronary disease. Br Heart J 1995; 73: 10-13.
28. Morley JJ, Kushner I. Serum C-reactive protein levels in disease. Ann NY Acad Sci 1982, 389: 406-418.
29. a ed.). Baltimore: Williams & Wilkins, 1987; 505-514.
30. Cermak J, Key NS, Bach RR, Balla J, Jacb HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthetize tissue factor. Blood 1993; 82: 513-520.
31. Biasucci LM, Vitelli A, Liuzzo G, Attamura S, Caliguri G, Monaco C et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996; 94: 874-877.
32. Fossat C, Fahre D, Alimi Y, Bienvenu J, Aillaud MF, Lenoble M et al. Leukocyte activation study during occlusive arterial disease of the lower limb: effect of pentoxifylline infusion. J Cardiovasc Pharmacol 1995: 25: S96-S100.
33. Dosquet C, Weill D, Wautier JL. Cytokines and thrombosis. J Cardiovasc Pharmacol 1995; 25: S13-S19.
34. Johnson K, Aarden L, Choi Y, De Groot E, Creasey A. The proinflammatory cytokine response to coagulation and endotoxin in whole blood. Blood 1996; 87: 5051-5060.
35. Biasucci LM, Luizzo G, Caligiuri G, Van de Greef W, Quaranta G, Monaco C et al. Episodic activation of the coagulation system in unstable angina does not elicit an acute phase reaction. Am J Cardiol 1996; 77: 85-87.
36. Liuzzo G, Biasucci LM, Rebuzzi AG, Gallimore R, Caligiuri G, Lanza G et al. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation 1996; 94: 2373-2380.
37. Berck BC, Weintraub W, Alexander RW. Elevation of C reactive protein in «active» coronary disease. Am J Cardid 1990; 65: 168-172.
38. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-424.
39. Liuzzo G, Biasucci LM, Gallimore JR, Caligiuri G, Buffon A, Rebuzzi A et al. Enhanced inflammatory response in patients with pre-infarction angina. J Am Coll Cardiol 1999; 34: 1696-1703.
40. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349: 462-466.
41. Morrow DA, Rifai N, Antman AN, Weiner DL, McCabe CH, Cannon CP et al. C-reactive protein is a potent predictor of mortality independently or in combination with troponin T in acute coronary syndromes: a TIMI 11a substudy. J Am Coll Cardiol 1998; 31: 1460-1465.
42. Toss H, Lindahl B, Siegbahn A, Wallentin L. For the FRISC study group. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 1997; 96: 4204-4210.
43. Verheggen P, Maat M, Manger Cats V, Haverkate F, Zwinderman A, Kluft C et al. Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function. Eur Heart J 1999; 20: 567-574.
44. Ferreirós ER, Boissonnet CP, Pizarro R, García Merletti P, Corrado G, Cagide A et al. Elevated C-reactive protein at discharge is a strong independent predictor of 90-day outcome in unstable angina. Circulation 1999; 100: 1958-1963.
45. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999; 99: 855-860.
46. Bazzino O, Ferreiros E, García Merletti P, Boissonet C, Pizarro R, Corrado G et al. Independent and combined prognostic value of CRP and the stress-test in patients recovering from unstable angina (resumen). Circulation 1999; 100: 1-370.
47. Heeschen Ch, Hamm Ch, Bruemmer J, Simoons M, for the Capture investigators. Predictive value of C-reactive protein and troponin T in patients with unstable angina. A comparative analysis. J Am Coll Cardiol 2000; 35: 1535-1542.
48. Montalescot G, Philippe F, Ankri A, Vicaut E, Bearez E, Poulard JE et al, for the French Investigators of the ESSENCE Trial. Early increase of van Willebrand factor predicts adverse outcome in unstable coronary artery disease. Circulation 1998; 98: 294-299.
49. Kushner I, Broder ML, Karp D. Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest 1978, 61: 235-242.
50. Massen A, Rebuzzi AG, Cianflone D. Need for a composite risk stratification of patients with unstable coronary syndromes tailored to clinical practice. Circulation 1997; 96: 4143-4142.
51. Théroux P, Fuster V. Acute coronary syndromes. Unstable angina and non-Q-wave myocardial infarction. Circulation 1998; 97: 1195-1206.
52. Bazzino O, Tajer C, Paviotti C, Mele E, Trivi M, Piombo A. Clinical predictors of in-hospital prognosis in unstable angina. ECLA 3. Am Heart J 1999; 137: 322-331.
53. Coplan NL, Wallach ID. The role of exercise testing for evaluating patients with unstable angina. Am Heart J 1992; 124: 252-256.
54. Butman SM, Olson HG, Gardin JM, Piters KM, Hullet M, Butman L. Submaximal exercise testing after stabilization of unstable angina pectoris. J Am Coll Cardiol 1984; 4: 667-673.
55. Wilcox I, Freedman SB, Allman KC, Collins FL, Leitch JW, Kelly DT et al. Prognostic significance of a pre-discharge exercise test in risk stratification after unstable angina pectoris. J Am Coll Cardiol 1991; 18: 677-683.
56. Lin SS, Lauer MS, Marwick TH. Risk stratification of patients with medically treated unstable angina using exercise echocardiography. Am J Cardiol 1998; 82: 720-724.
57. Lauer MS. Noninvasive risk stratification after myocardial infarction: which test is best? Am Heart J 1998; 136: 565-569.
58. Krone RJ, Gregory JJ, Freedland KE, Kleiger RE, Wackers FJ, Bodenheimer MM et al. Limited usefulness of exercise testing and thallium scintigraphy in evaluation of ambulatory patients several months after recovery from acute coronary event: implications for management of stable coronary disease. J Am Coll Cardiol 1994; 24: 1274-1281.
59. Rebuzzi AG, Quaranta G, Liuzzo G, Caligiuri G, Lanza GA, Gallimore JR et al. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris. Am J Cardiol 1998; 82: 715-719.
60. De Winter RJ, Bholasingh R, Koster RW, Gorgels JPMC, Scouten Y, Hoek FJ et al. Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q wave myocardial infarction. Cardiovasc Res 1999; 42: 240-245.
61. Homvang L, Lüscher M, Clemmensen P, Thygesen K, Grande P, and TRIM Study Group. Very early risk stratification using combined ECG and biochemical assessment in patients with unstable coronary artery disease (a thrombin inhibition in myocardial ischemia (TRIM substudy). Circulation 1998; 98: 2004-2009.
62. Lindahl B, Andrén B, Ohlsson J, Venge P, Wallentin L, for the FRISC Study Group. Risk stratification in unstable coronary artery disease: additive value of troponin T determinations and pre-discharge exercise tests. Eur Heart J 1997; 18: 762-770.